ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BCDA vs SCLX // PIOTROSKI F-SCORE QUALITY

BioCardia Inc. (NASDAQ) VS. Scilex Holding Company (NASDAQ) • 15-METRIC TALLY: BCDA 1 — SCLX 2
▲ PIOTROSKI F-SCORE QUALITY LEADER: SCLX
piotroski-score
4/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BCDA VS. SCLX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BCDA SCLX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 96.00% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — 21.05% — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — -46.50% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 2/9 4/9 -2.00 SCLX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 37.5 14.0 +23.49 BCDA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $14.0M $17.5M -$3.5M SCLX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BCDA REV SCLX REV BCDA GROSS % SCLX GROSS % BCDA FCF SCLX FCF
FY 2025 $0 $30.3M — 98.0% -$7.4M $3.7M
FY 2024 $0 $56.6M — 98.0% -$7.9M $19.3M
FY 2023 $0 $46.7M — — -$10.0M -$20.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BCDA // BETA —
SCLX // BETA —